The American Hospital Association (AHA) and the Centers for Disease Control and Prevention (CDC) today issued a new patient-friendly resource on prescription opioids. 

“Every day, hospitals see how misuse of and overdose from prescription opioids affects patients’ families, loved ones and communities,” said AHA President and CEO Rick Pollack. “We want patients to have open, honest conversations with their care providers about the best way to manage pain. The goal is to help patients manage their pain and continue to lead healthy, productive lives. We are pleased to work with the CDC to develop and share this new resource with hospitals and care providers across the country.”

Patients and consumers can use the resource to talk to their physicians about the risks and benefits of prescription opioids, how to use these medications as safely and effectively as possible, and ways to manage pain that do not involve prescription opioids.

The new patient resource is available on CDC.gov and AHA.org. For more information on how the AHA and CDC are addressing the opioid abuse crisis: 

Related News Articles

Headline
The AHA has updated the Stress and Coping Resources website, which contains valuable information and resources to support mental well-being for both health…
Headline
Jason Lesandrini, Ph.D., assistant vice president of ethics, advanced care planning, spiritual health and language access services at Wellstar Health System,…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The U.S. has had 935 confirmed cases of measles so far this year, according to the latest data from the Centers for Disease Control and Prevention. Cases have…
Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…